Kino Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 26, 2021 at 07:23 pm EDT
Share
Kino Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 97.402 million compared to TWD 124.762 million a year ago. Operating loss was TWD 13.427 million compared to TWD 5.217 million a year ago. Net loss was TWD 16.032 million compared to TWD 6.187 million a year ago. Basic loss per share from continuing operations was TWD 0.54 compared to TWD 0.26 a year ago. For the half year, total revenue was TWD 207.787 million compared to TWD 287.790 million a year ago. Operating loss was TWD 45.111 million compared to operating Income of TWD 17.199 million a year ago. Net loss was TWD 38.932 million compared to net income of TWD 20.976 million a year ago. Basic loss per share from continuing operations was TWD 1.31 compared to basic earnings per share from continuing operations of TWD 0.86 a year ago.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.
RAKU CO., LTD 
